MedPath

The effect of desmopressin in reducing the pain of renal colic patientsSearch for this on Google

Phase 3
Recruiting
Conditions
The effect of adding sublingual desmopressin to the intravenous treatment with Apotel and ketorolac in patients with mild to moderate renal colic pain.
Registration Number
IRCT20230704058673N1
Lead Sponsor
Ahvaz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
102
Inclusion Criteria

All patients with renal colic who have not received painkillers in the last three hours
Do not have hypertension
Do not have coronary artery disease
Do not have gastric ulcers
Do not have renal failure
Do not have liver failure
Do not pregnant
Do not take anticoagulants

Exclusion Criteria

Patients who become unstable in terms of vital signs
Have changes in blood pressure
Tachycardia
Headache
dizziness
seizure
Occurrence of drug side effects
Intolerance of pain during the study

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Intensity of pain. Timepoint: zero, 15 minutes, 30 minutes, 45 minutes, 60 minutes,. Method of measurement: Using the visual analog scale (VAS) for this purpose, the printed VAS ruler is shown to the patients and they are asked to indicate the number that represents their current pain.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath